HER2 Inhibition in Gastric Cancer—Novel Therapeutic Approaches for an Established Target

por Fong, Caroline, Chau, Ian
Publicado 2022

Targeted Therapies and Developing Precision Medicine in Gastric Cancer

por Pihlak, Rille, Fong, Caroline, Starling, Naureen
Publicado 2023

Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma

por Fong, Caroline Y. K., Burke, Emma, Cunningham, David, Starling, Naureen
Publicado 2019

Activity and toxicity of intramuscular 1000 iu/m(2) polyethylene glycol‐E. coli L‐asparaginase in the UKALL 2003 and UKALL 2011 clinical trials

por Sidhu, Jasmeet, Masurekar, Ashish Narayan, Gogoi, Manash Pratim, Fong, Caroline, Ioannou, Tasos, Lodhi, Taha, Parker, Catriona, Liu, Jizhong, Kirkwood, Amy A., Moorman, Anthony V., Das, Kiranmoy, Goulden, Nicholas J., Vora, Ajay, Saha, Vaskar, Krishnan, Shekhar
Publicado 2022

Impact of pharmacogenomic DPYD variant guided dosing on toxicity in patients receiving fluoropyrimidines for gastrointestinal cancers in a high-volume tertiary centre

por Lau, David K., Fong, Caroline, Arouri, Faten, Cortez, Lillian, Katifi, Hannah, Gonzalez-Exposito, Reyes, Razzaq, Muhammad Bilal, Li, Su, Macklin-Doherty, Aislinn, Hernandez, Monica Arenas, Hubank, Michael, Fribbens, Charlotte, Watkins, David, Rao, Sheela, Chau, Ian, Cunningham, David, Starling, Naureen
Publicado 2023